Edition:
United Kingdom

Aspen Pharmacare Holdings Ltd (APNJ.J)

APNJ.J on Johannesburg Stock Exchange

10,162.00ZAc
19 Jun 2019
Change (% chg)

395.00 (+4.04%)
Prev Close
9,767.00
Open
9,849.00
Day's High
10,262.00
Day's Low
9,777.00
Volume
1,558,077
Avg. Vol
1,935,585
52-wk High
29,800.00
52-wk Low
6,899.00

Select another date:

Mon, May 20 2019

Photo

South Africa's Aspen sells Australian prescription portfolio to Mylan

JOHANNESBURG Aspen Pharmacare said on Monday that Mylan NV had exercised an option to buy the South African drugmaker's portfolio of prescription and over-the-counter products in Australia for 188 million Australian dollars ($130 million).

UPDATE 1-South Africa's Aspen sells Australian prescription portfolio to Mylan

JOHANNESBURG, May 20 Aspen Pharmacare said on Monday that Mylan NV had exercised an option to buy the South African drugmaker's portfolio of prescription and over-the-counter products in Australia for 188 million Australian dollars ($130 million).

South Africa's Aspen sells Australian prescription portfolio to Mylan

JOHANNESBURG, May 20 Aspen Pharmacare said on Monday that Mylan NV had exercised an option to buy Aspen's portfolio of prescription and over-the-counter products in Australia for 188 million Australian dollars ($130 million).

UPDATE 1-South Africa's rand recovers after U.S. jobs data, stocks slide on Aspen

JOHANNESBURG, March 8 South Africa's rand firmed on Friday, recovering from a nine-week low after sluggish U.S. employment data pushed the dollar lower and saw demand for emerging markets return.

UPDATE 2-Shares in S.Africa's Aspen plunge on debt, slow sale proceeds

* Debt levels still within creditor threshold (Adds historical debt, details)

Aspen shares plunged by nearly 40 pct on debt worries

JOHANNESBURG, March 8 Shares of South Africa-based drugmaker Aspen Pharmacare plunged nearly 40 percent on Friday, as rising debt worried investors.

UPDATE 1-Aspen to split South African pharma business after disposal of non-core assets

JOHANNESBURG, March 7 Multinational drugmaker Aspen Pharmacare said it will split its South African Commercial Pharmaceuticals business into two divisions as it disposes of non-core assets to reduce its debt.

Select another date: